FORMULATION AND IMMUNOSTIMULANT STABILITY POLYSACCHARIDE SYRUP OF FRACTION NONI (MORINDA CITRIFOLIA L.) FRUITS
Objective: The study aimed to formulate standardized polysaccharide fraction of Noni (SPFN) fruit into syrup preparations to fulfill the acceptability requirement of National Agency of Drugs and Food Control [Badan Pengawas Obat dan Makanan Republik of Indonesia (BPOM RI)] so that it can be used in the community as an immunostimulant.
Methods: The optimization of the formula A and B were done using Simplex Lattice Design (SLD) method and its stability tested under extreme temperature change effect using thaw cycling method by evaluating the physical properties, microbial contamination and immunostimulant activity. MTT method was used to determine the immunostimulant activity of syrup against lymphocyte proliferation in vitro.
Results: Based on the results of stability tests of formula A using pH (4.45), viscosity (81.03 mPas), taste (good taste), pouring power (2.31 s), amount of bacteria (68 colonies/ml), total yeast and mold (269 colonies/ml) parameters and fulfilled the acceptability requirement of BPOM RI. Formula A could maintain better stability than formula B. Formula A syrup used for immunostimulant activity testing that could increase lymphocyte proliferation at a concentration of 13.33 to 106.64 μg/μl and it’s stable under the influence of extreme temperature changes.
Conclusion: Formula A could be used to produce SPFN syrup, which has stable physical properties and immunostimulant activity beside no microbial contamination that fulfill requirements of BPOM RI.
2. Cseke LJ, Kirakosyan A, Kaufman PB, Warber S, Duke JA, Brielman HL. Natural product from plant. 2nd ed. CRC Press. USA; 2016. p. 27-30.
3. Ramberg JE, Nelson ED, Sinnott RA. Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J 2010;9:54.
4. Wang M, West B, Jensen C, Nowicki D, Su C, Palu A, et al. Morinda citrifolia (noni). a literature review and recent advances in noni research. Acta Pharmacol Sin 2002;23:1127-41.
5. Hirazumi A, Furusawa E, Chou SC, Hokama Y. Immunomodulation contributes to the anti-cancer activity of morinda citrifolia (noni) fruit juice. Proc West Pharmacol Soc 1996;39:25-7.
6. Palu A, Hirazumi A, West B, Deng S, Jensen J, White L. The effects of Morinda citrifolia L. (noni) on the immune system: Its molecular mechanism of action. J Ethnopharmacol 2008;115:502-6.
7. Ediati S, Hertiani T, Kartika S, Maharani FP, Setiawan V, Narastika L. optimization of polysaccharide-rich fractionation from morinda citrifolia L., fruit based on immunostimulatory effect in vitro. Indonesian J Pharm 2015;26:78-85.
8. Ediati S, Lukitaningsih E, Rumiyati. Noni fruit as bio-immunostimulant material: characterization of a purified polysaccharide fraction of Morinda citrifolia L. fruit. The proceeding of DAAD conference on health management in post disaster recovery; 2017.
9. Kaushik A, Chauhan V, Sudha Dr. Formulation and evaluation of herbal cough syrup. Eur J Pharm Med Res 2016;3:517-22.
10. Supriyatna MW, Iskandar Y, Febriyanti MR. Prinsip obat herbal: sebuah pengantar untuk fitoterapi. Edisi 1. 47. Deepublish. Yogyakarta, Indonesia; 2014.
11. Jones DS. Pharmaceutics dosage form and design. 2nd ed. Pharmaceutical Press: London; 2016. p. 1-21.
12. BPOM RI. Peraturan kepala BPOM No. 12 tahun 2014 tentang persyaratan mutu obat tradisional: BPOM. Jakarta; 2014. p. 15-6.
13. Hill R. What sample size is “enough” in internet survey research. Interpersonal Computing Technol: Electronic J 1998;6:1-12.
14. Mohammed K, Fatima B, Abdennour B, Lackhdar A. The fit between strategic choice and organization structure and their impact on the effectiveness of the organization: study of a set of medium and large instutution in Algeria. Int J Bus Soc Sci 2017;1:1-9.
15. Lisprayatna L, Bayu YM, Saifullah TNS. Formulasi sirup ekstrak daun legundi (Vitex trifolia L.). Trad Med J 2012;17:34-8.
16. Ansel HC, Allen LV, Popovich NG. Ansel’s pharmaceutical dosage forms and drug delivery systems. Lippinacott Willliams and Wilkins. 9th ed. United States of America; 2002. p. 374-9.
17. Allen LV, Ansel HC. Ansel’s pharmaceutical dosage forms and drug delivery systems. 10th ed. Lippincott Williams and Wilkins, Baltimore; 2014. p. 411-5.
18. Martin AN, Sinko PJ, Singh Y. Martin’s physical pharmacy and pharmaceutical science. 6th ed. Lippincott Williams and Wilkins, Philadelphia; 2011.
19. Ediati S, Harimurti S, Nurhidayat H, Anggoro W, Hikmawati EN, Wibowo JT, et al., Influence of Morinda citrifolia, L. fruit extract as adjuvant on Ig-Y production raised in laying chickens against avian influenza vaccine. Indonesian J Pharm 2012;2:115-20.
20. Ediati S, Hertiani T, Renggani TN, Asawimanda NA, Laksana BJ, Pratomo WP. The polysaccharide-rich fraction of noni fruit (Morinda citrifolia L.) as doxorubicin co-chemotherapy: evaluation of catalase, macrophages, and TCD8+lymphocytes. Sci Pharm 2015;83:479-88.
21. Chen XT, Li Y, Wang HL, Cheng WM, Zhang L, Ge JF. Immunomodulating effects of fractioned polysaccharides isolated from yuping-feng-powder in cyclophosphamide-treated mice. Am J Chin Med 2016;34:631-41.
22. Sambasivarao A, Baru CSR, Reddy MH. Accelerated stability testing of dosage forms as per International Conference of Harmonization (ICH) Guidelines. World J Pharm Med Res 2016;2:99-103.
23. Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. Pharmaceutical Press: London; 2009.
This work is licensed under a Creative Commons Attribution 4.0 International License.